Show simple item record

dc.contributor.authorYılmaz, Mehmet Kürşat
dc.contributor.authorAbbaszadeh, Ahmad
dc.contributor.authorTarabichi, Saad
dc.contributor.authorAzboy, İbrahim
dc.contributor.authorParvizi, Javad
dc.date.accessioned2023-07-10T09:04:59Z
dc.date.available2023-07-10T09:04:59Z
dc.date.issued2023en_US
dc.identifier.citationYılmaz, M. K., Abbaszadeh, A., Tarabichi, S., Azboy, İ. ve Parvizi, J. (2023). Diagnosis of periprosthetic joint infection: The utility of biomarkers in 2023. Antibiotics-Basel, 12(6). https://dx.doi.org/10.3390/antibiotics12061054en_US
dc.identifier.issn2079-6382
dc.identifier.urihttps://dx.doi.org/10.3390/antibiotics12061054
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11174
dc.description.abstractPeriprosthetic joint infection (PJI) is a rare yet devastating complication following total joint arthroplasty (TJA). Early and accurate diagnosis of PJI is paramount in order to maximize the chances of successful treatment. However, we are yet to identify a single "gold standard" test for the diagnosis of PJI. As a result, the diagnosis of PJI is often challenging. Currently, the 2018 ICM definition of PJI is the only validated diagnostic criteria available. This article will review the importance of serum and synovial biomarkers in the diagnosis of PJI. In addition, it will provide a brief overview of the emerging modalities for the identification of infections in this setting.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectPeriprosthetic Joint Infectionen_US
dc.subjectSerumen_US
dc.subjectSynovial Fluiden_US
dc.subjectMarkeren_US
dc.titleDiagnosis of periprosthetic joint infection: The utility of biomarkers in 2023en_US
dc.typereviewen_US
dc.relation.ispartofAntibiotics-Baselen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Ortopedi ve Travmatoloji Ana Bilim Dalıen_US
dc.authorid0000-0002-6398-281Xen_US
dc.authorid0000-0003-0926-3029en_US
dc.identifier.volume12en_US
dc.identifier.issue6en_US
dc.relation.publicationcategoryDiğeren_US
dc.identifier.doi10.3390/antibiotics12061054en_US
dc.institutionauthorYılmaz, Mehmet Kürşat
dc.institutionauthorAzboy, İbrahim
dc.identifier.wosqualityQ1en_US
dc.identifier.wos001013826700001en_US
dc.identifier.scopus2-s2.0-85163757312en_US
dc.identifier.pmid37370373en_US
dc.identifier.scopusqualityQ1en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess